June 5, 2023 Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update View Article
May 31, 2023 KAHR Reports Dose Escalation Results from Phase I Trial of DSP107 in Combination with anti-PD-L1 in Patients with Advanced Solid Tumors View Article
May 30, 2023 Nutex Health Inc. Announces Agreement with MeMed to Adopt Pioneering MeMed BV® Test Across its Network of 19 sites View Article
May 22, 2023 PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections View Article
May 17, 2023 Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University View Article
May 11, 2023 Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open View Article
May 10, 2023 Yotpo Launches eCommerce Retention Marketing Platform and New Pricing to Combat Rising Customer Acquisition Costs and Lower Total Cost of Ownership View Article
